OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
XERS holding history
Xeris Biopharma Holdings, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XERS overviewAll 13F holders of XERSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −80,420−100.0% | Sold out | Holders |
| Q3 2025 | 80,420 | $654.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 80,420 | $375.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 80,420 | $441.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 80,420 | $272.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 80,420 | $229.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 80,420 | $180.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 80,420 | $177.7K | <0.1% | +80,420 | New | Holders |